van Puijenbroek M - Search Results

1

Genome-wide copy neutral LOH is infrequent in familial and sporadic microsatellite unstable carcinomas.

van Puijenbroek M, Middeldorp A, Tops CM, van Eijk R, van der Klift HM, Vasen HF, Wijnen JT, Hes FJ, Oosting J, van Wezel T, Morreau H. van Puijenbroek M, et al. Among authors: van eijk r, van der klift hm, van wezel t. Fam Cancer. 2008;7(4):319-30. doi: 10.1007/s10689-008-9194-8. Epub 2008 Apr 15. Fam Cancer. 2008. PMID: 18415027

2

Microsatellite instability, immunohistochemistry, and additional PMS2 staining in suspected hereditary nonpolyposis colorectal cancer.

de Jong AE, van Puijenbroek M, Hendriks Y, Tops C, Wijnen J, Ausems MG, Meijers-Heijboer H, Wagner A, van Os TA, Bröcker-Vriends AH, Vasen HF, Morreau H. de Jong AE, et al. Among authors: van puijenbroek m, van os ta. Clin Cancer Res. 2004 Feb 1;10(3):972-80. doi: 10.1158/1078-0432.ccr-0956-3. Clin Cancer Res. 2004. PMID: 14871975

3

The natural history of a combined defect in MSH6 and MUTYH in a HNPCC family.

van Puijenbroek M, Nielsen M, Reinards TH, Weiss MM, Wagner A, Hendriks YM, Vasen HF, Tops CM, Wijnen J, van Wezel T, Hes FJ, Morreau H. van Puijenbroek M, et al. Among authors: van wezel t. Fam Cancer. 2007;6(1):43-51. doi: 10.1007/s10689-006-9103-y. Fam Cancer. 2007. PMID: 17039270

4

HNPCC versus sporadic microsatellite-unstable colon cancers follow different routes toward loss of HLA class I expression.

Dierssen JW, de Miranda NF, Ferrone S, van Puijenbroek M, Cornelisse CJ, Fleuren GJ, van Wezel T, Morreau H. Dierssen JW, et al. Among authors: van puijenbroek m, van wezel t. BMC Cancer. 2007 Feb 22;7:33. doi: 10.1186/1471-2407-7-33. BMC Cancer. 2007. PMID: 17316446 Free PMC article.

5

Identification of patients with (atypical) MUTYH-associated polyposis by KRAS2 c.34G > T prescreening followed by MUTYH hotspot analysis in formalin-fixed paraffin-embedded tissue.

van Puijenbroek M, Nielsen M, Tops CM, Halfwerk H, Vasen HF, Weiss MM, van Wezel T, Hes FJ, Morreau H. van Puijenbroek M, et al. Among authors: van wezel t. Clin Cancer Res. 2008 Jan 1;14(1):139-42. doi: 10.1158/1078-0432.CCR-07-1705. Clin Cancer Res. 2008. PMID: 18172263

6

Genome-wide allelic state analysis on flow-sorted tumor fractions provides an accurate measure of chromosomal aberrations.

Corver WE, Middeldorp A, ter Haar NT, Jordanova ES, van Puijenbroek M, van Eijk R, Cornelisse CJ, Fleuren GJ, Morreau H, Oosting J, van Wezel T. Corver WE, et al. Among authors: van puijenbroek m, van eijk r, van wezel t. Cancer Res. 2008 Dec 15;68(24):10333-40. doi: 10.1158/0008-5472.CAN-08-2665. Cancer Res. 2008. PMID: 19074902

7

Colorectal carcinomas in MUTYH-associated polyposis display histopathological similarities to microsatellite unstable carcinomas.

Nielsen M, de Miranda NF, van Puijenbroek M, Jordanova ES, Middeldorp A, van Wezel T, van Eijk R, Tops CM, Vasen HF, Hes FJ, Morreau H. Nielsen M, et al. Among authors: van puijenbroek m. BMC Cancer. 2009 Jun 15;9:184. doi: 10.1186/1471-2407-9-184. BMC Cancer. 2009. PMID: 19527492 Free PMC article.

8

Comprehensive genetic analysis of seven large families with mismatch repair proficient colorectal cancer.

Middeldorp A, Jagmohan-Changur SC, van der Klift HM, van Puijenbroek M, Houwing-Duistermaat JJ, Webb E, Houlston R, Tops C, Vasen HF, Devilee P, Morreau H, van Wezel T, Wijnen J. Middeldorp A, et al. Among authors: van puijenbroek m. Genes Chromosomes Cancer. 2010 Jun;49(6):539-48. doi: 10.1002/gcc.20763. Genes Chromosomes Cancer. 2010. PMID: 20222047

9

Early onset MSI-H colon cancer with MLH1 promoter methylation, is there a genetic predisposition?

van Roon EH, van Puijenbroek M, Middeldorp A, van Eijk R, de Meijer EJ, Erasmus D, Wouters KA, van Engeland M, Oosting J, Hes FJ, Tops CM, van Wezel T, Boer JM, Morreau H. van Roon EH, et al. Among authors: van puijenbroek m. BMC Cancer. 2010 May 5;10:180. doi: 10.1186/1471-2407-10-180. BMC Cancer. 2010. PMID: 20444249 Free PMC article.

10

Molecular analysis of hereditary nonpolyposis colorectal cancer in the United States: high mutation detection rate among clinically selected families and characterization of an American founder genomic deletion of the MSH2 gene.

Wagner A, Barrows A, Wijnen JT, van der Klift H, Franken PF, Verkuijlen P, Nakagawa H, Geugien M, Jaghmohan-Changur S, Breukel C, Meijers-Heijboer H, Morreau H, van Puijenbroek M, Burn J, Coronel S, Kinarski Y, Okimoto R, Watson P, Lynch JF, de la Chapelle A, Lynch HT, Fodde R. Wagner A, et al. Among authors: van puijenbroek m, van der klift h. Am J Hum Genet. 2003 May;72(5):1088-100. doi: 10.1086/373963. Epub 2003 Mar 25. Am J Hum Genet. 2003. PMID: 12658575 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

40 results

Search Page